NYSE most active: Bank of America (NYSE:BAC), Pfizer Inc. (NYSE:PFE), Verizon Communications (NYSE:VZ), Petroleo Brasileiro Petrobras (NYSE:PBR)

Atlantic Equities downgrades shares of Bank of America (NYSE:BAC) from Overweight to Neutral and lowered the price target from $20 to $18.50 Bank of America Corp (NYSE:BAC) stock performance was -1.08% in last session and finished the day at $17.37. Traded volume was 118,100,416 million shares in the last session and the average volume of the stock remained 109.13 million shares. The beta of the … Continue reading NYSE most active: Bank of America (NYSE:BAC), Pfizer Inc. (NYSE:PFE), Verizon Communications (NYSE:VZ), Petroleo Brasileiro Petrobras (NYSE:PBR)

Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY), Merck & Co (NYSE:MRK)

US pharma giant Pfizer (NYSE:PFE) has announced detailed results from OPT Compare (A3921080), a Phase III study of tofacitinib (trade name Xeljanz), the first in a new class of treatment, oral Janus kinase (JAK) inhibitors, the safety and efficacy of which are being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis. Pfizer Inc. (NYSE:PFE) stock performance was -2.14% in last session and … Continue reading Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY), Merck & Co (NYSE:MRK)

Trading in Pfizer Inc. (NYSE:PFE) was halted last week because of pending news. While we see that all the time in smaller biotechs, MannKind will likely be halted next week during an FDA advisory committee meeting. Pfizer Inc. (NYSE:PFE) stock performance was 0.85% in last session and finished the day at $32.18. Traded volume was 62.72million shares in the last session and the average volume … Continue reading Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Abbott Laboratories (NYSE:ABT), Zogenix Inc. (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX)

Arena Pharmaceuticals Inc (NASDAQ: ARNA ) and VIVUS (NASDAQ: VVUS ) in early 2012 as each company headed into their regulatory reviews with the U.S. Food and Drug Administration, or FDA, for their respective obesity medications. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was -2.84% in last session and finished the day at $6.49. Traded volume was 6.83million shares in the last session and the average … Continue reading Active Stocks Healthcare: Arena Pharmaceuticals (NASDAQ:ARNA), Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), Teva Pharmaceutical Industries (NYSE:TEVA)

A US federal court yesterday invalidated Pfizer Inc.’s (NYSE:PFE) key patent covering its anti-inflammatory pill Celebrex. The patent, which was set to lapse in December 2015, would have given Pfizer an 18-month extension from the expiry of the patent for the major ingredient in the drug, celecoxib. Pfizer Inc. (NYSE:PFE) stock performance was -2.69% in last session and finished the day at $31.12. Traded volume … Continue reading Biotech Active Stocks: Pfizer Inc. (NYSE:PFE), Geron Corporation (NASDAQ:GERN), Cell Therapeutics (NASDAQ:CTIC), Chelsea Therapeutics International (NASDAQ:CHTP)

Shares of Plug Power Inc (NASDAQ:PLUG) rose Thursday after the company narrowed a quarterly per-share loss and said it expected to break even this year and quadruple orders. Plug Power Inc (NASDAQ:PLUG) stock performance was 17.65% in last session and finished the day at $8.00. Traded volume was 130,939,920 million shares in the last session and the average volume of the stock remained 37.58 million … Continue reading Investor’s Alert: Plug Power Inc (NASDAQ:PLUG), SIRIUS XM Holding (NASDAQ:SIRI), General Electric Company (NYSE:GE), Pfizer Inc. (NYSE:PFE)